Description: Dana M. Peterson, chief economist for the Conference Board, has established herself as a visionary, and the go to expert providing insightful analysis and predictions to corporations, associations, and government organizations looking for clarity and foresight into how economic drivers might impact their businesses in the short- and long-term. With over two decades of experience in the field, she serves as the globally recognized think tank’s public face and primary spokesperson on all things related to the economy.

Description: In this talk, we look at two behavioral aspects: from end customers perspective and through the lens of underwriters. We will examine simple rules to improve the insurance underwriting decision to judge whether a risk is insurable and whether they have impact on increasing underwriting decision quality.

Description: The insurance industry recently adopted two significant accounting changes. Good risk management requires a solid understanding of new risks as well as a proper set of controls. Learn how internal audit can help actuaries better understand arising risks and build a more robust control framework.

Description: "Spread pricing is a pricing methodology where pharmacy benefit managers (PBMs) bill a payer one price but reimburses the dispensing pharmacy a lower price for the same prescription drug. PBMs have historically relied on spread pricing as a revenue source. However, a growing number of states are introducing and passing legislation prohibiting spread pricing for Medicaid and commercial clients. In addition, new entrants to the PBM and mail-order pharmacy space are disrupting the market by offering services that promote increased transparency and member satisfaction. Expect updates on recent legislative trends and market disruptions targeted towards increasing PBM drug pricing transparency. By attending this session, you will have a better understanding of how changing legislation and market disruptions may impact current pricing methodologies."

Description: "Hear an overview of recent results and potential scenarios that may impact the future of the ACA market. Review recent reported industry level profitability before transitioning to a discussion of how current market dynamics may influence the future profitability of this segment. Results from microsimulation economic models will be presented to help illuminate market shifts. Issues that will be explored include how ICRA availability might influence individual decision making, as well as how a move to level funding is impacting the small group market. By attending this session, you will: Understand the recent average and variation of industry performance in the ACA market segment. Describe current policy and market forces that are expected to impact this segment. Explain the range of market scenarios that may result due to these forces."

Description: Risk is opportunity! Equipped with skills to analyze risks, actuaries are no longer limited to applying these skills solely within traditional actuarial roles. Listen in as the presenters share their career experience in a non-traditional role and provide insights on how being an actuary can bring additional value to the profession.

Description: The Society of Actuaries will be offering this webinar series intended to educate and investigate aspects of life insurance, annuity, and long-term care product tax compliance. Developed by the Taxation Section, participants will be brought up to date on recent Internal Revenue Service (IRS) guidance and learn about the newest tax issues related to product design and administration. Legal, IRS and product development experts will provide vital insights into the challenges of developing and administering products within the requirements of the Internal Revenue Code (IRC) and allow ample opportunities for questions and information exchange. This session will provide an intense introduction to the basics of product taxation, with a focus on life insurance and the requirements of Section 7702A.

Description: This three-part series provides an overview of the rapidly evolving and dynamic gene and cellular therapy landscape, from the clinical, historical, and risk transfer perspectives. It covers the actuarial considerations in pricing cell and gene insurance and reinsurance, the value assessment of the therapies, manufacturer pricing, and reinsurance cost.

Description: Defining fairness for life insurance processes is complex and challenging as well as subjective. This webcast will be a discussion of the challenges and opportunities presented as our profession rethinks fairness in the context of processes involved in developing and managing life insurance, especially risk classification.

Description: Exploring the SOA Exam Pathway in India